Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Trond J. Cooper"'
Publikováno v:
European Journal of Heart Failure. 24:1990-1992
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58699b421877767354385411d1e84880
https://doi.org/10.1002/ejhf.2690
https://doi.org/10.1002/ejhf.2690
Autor:
Stefan D. Anker, Kenneth Dickstein, Josep Comín-Colet, Piotr Ponikowski, Claudio Mori, Gerasimos Filippatos, Trond J. Cooper, Thomas F. Lüscher, Mitja Lainscak, Patrick W. Johnson
Publikováno v:
The American Journal of Cardiology. 117:1482-1487
Clinical status in heart failure is conventionally assessed by the physician's evaluation, patients' own perception of their symptoms, quality of life (QoL) tools, and a measure of functional capacity. These aspects can be measured with tools such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1e022bbd3ccb2e50f15ec25fcf05a0d
https://doi.org/10.1016/j.amjcard.2016.02.018
https://doi.org/10.1016/j.amjcard.2016.02.018
Publikováno v:
Tidsskrift for Den norske legeforening. 136:1010-1014
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2b198a1cf5a1368206b82a893bfc0d4
https://doi.org/10.4045/tidsskr.15.0958
https://doi.org/10.4045/tidsskr.15.0958
Autor:
Offer Amir, Trond J. Cooper, Marco Guazzi, Kenneth Dickstein, Tuvia Ben-Gal, Abdallah Al-Mohammad, John G.F. Cleland
Publikováno v:
European journal of heart failure. 15(1)
Aims Heart failure (HF) is a major clinical problem and, despite advances in both pharmacological and device therapy, the mortality remains high and quality of life poor. Over the last decade there has been growing interest in using phosphodiesterase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eabaf47d3f751cea436e5429c4e61d0
https://pubmed.ncbi.nlm.nih.gov/23097067
https://pubmed.ncbi.nlm.nih.gov/23097067